These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 14563320)

  • 21. IFN-producing killer dendritic cells are antigen-presenting cells endowed with T-cell cross-priming capacity.
    Pletneva M; Fan H; Park JJ; Radojcic V; Jie C; Yu Y; Chan C; Redwood A; Pardoll D; Housseau F
    Cancer Res; 2009 Aug; 69(16):6607-14. PubMed ID: 19679552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cells and dendritic cells: rendezvous in abused tissues.
    Moretta A
    Nat Rev Immunol; 2002 Dec; 2(12):957-64. PubMed ID: 12461568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breaking tolerance to tumors with dendritic cell-based immunotherapy.
    Mende I; Engleman EG
    Ann N Y Acad Sci; 2005 Nov; 1058():96-104. PubMed ID: 16394129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of myeloid dendritic cells retrovirally transduced to express mammalian or viral interleukin-10 on cytotoxic T lymphocyte and natural killer cell functions and resistance to tumor growth.
    Takayama T; Tahara H; Thomson AW
    Transplantation; 2001 May; 71(9):1334-40. PubMed ID: 11397973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. H2-M3-restricted CD8+ T cells augment CD4+ T-cell responses by promoting DC maturation.
    Chow MT; Teh HS
    Eur J Immunol; 2010 May; 40(5):1408-17. PubMed ID: 20162552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
    J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells.
    Holtappels R; Thomas D; Podlech J; Geginat G; Steffens HP; Reddehase MJ
    J Virol; 2000 Feb; 74(4):1871-84. PubMed ID: 10644360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
    Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
    Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen.
    Vankayalapati R; Klucar P; Wizel B; Weis SE; Samten B; Safi H; Shams H; Barnes PF
    J Immunol; 2004 Jan; 172(1):130-7. PubMed ID: 14688318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Porcine T lymphocytes and NK cells--an update.
    Gerner W; Käser T; Saalmüller A
    Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.
    Moretta A; Vitale M; Bottino C; Orengo AM; Morelli L; Augugliaro R; Barbaresi M; Ciccone E; Moretta L
    J Exp Med; 1993 Aug; 178(2):597-604. PubMed ID: 8340759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MHC class I+/II- dendritic cells induce hapten-specific immune responses in vitro and in vivo.
    Kolesaric A; Stingl G; Elbe-Bürger A
    J Invest Dermatol; 1997 Oct; 109(4):580-5. PubMed ID: 9326394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cells need T cell help to prime cytotoxic T cell responses to strong antigens.
    Livingstone AM; Kuhn M
    Eur J Immunol; 1999 Sep; 29(9):2826-34. PubMed ID: 10508257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in viral evasion of the MHC Class I processing pathway.
    Schuren AB; Costa AI; Wiertz EJ
    Curr Opin Immunol; 2016 Jun; 40():43-50. PubMed ID: 27065088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
    Fujii S; Shimizu K; Hemmi H; Steinman RM
    Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells.
    Tanaka Y; Koido S; Ohana M; Liu C; Gong J
    J Immunol; 2005 Feb; 174(3):1274-80. PubMed ID: 15661883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers.
    Bohnenkamp HR; Coleman J; Burchell JM; Taylor-Papadimitriou J; Noll T
    Cell Immunol; 2004; 231(1-2):112-25. PubMed ID: 15919376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.